SETTLEMENT AGREEMENTSettlement Agreement • October 8th, 2019 • Camac Fund, LP • Radio broadcasting stations • New York
This SETTLEMENT AGREEMENT (this “Agreement”) is made and entered into as of October 4, 2019, by and among Liberated Syndication, Inc., a Nevada corporation (the “Company”), on the one hand, and Camac Fund, LP and Mr. Eric Shahinian (collectively, the “Stockholders”), on the other hand.
JOINT FILING AGREEMENTJoint Filing Agreement • August 1st, 2022 • Camac Fund, LP • Pharmaceutical preparations
This JOINT FILING AGREEMENT is entered into as of December 30, 2019, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of Common Stock of Forte Biosciences, Inc., and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
MEMORANDUM OF AGREEMENTMemorandum of Agreement • November 8th, 2022 • Camac Fund, LP • Gold and silver ores • Alberta
THIS MEMORANDUM of AGREEMENT dated November 7, 2022 (this “Agreement“) is made by and among (i) Camac Partners, LLC, (ii) Camac Fund, LP, (iii) Camac Fund II, LP (together with Camac Partners, LLC and Camac Fund, LP, the “Camac Group“), and (iv) Gold Reserve Inc. (“Gold Reserve”). Each member of the Camac Group and Gold Reserve are collectively referred to as the “Parties”.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • January 4th, 2018 • Camac Fund, LP • Industrial & commercial fans & blowers & air purifing equip
The undersigned acknowledge and agree that the foregoing statement of Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement of Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • April 26th, 2019 • Camac Fund, LP • Radio broadcasting stations • Delaware
This joint filing and solicitation agreement (this “Agreement”), dated April 26, 2019, is between (a) Camac Fund, LP, Camac Partners, LLC, Camac Capital, LLC and Eric Shahinian (collectively, the “Camac Entities”); and (b) Michael Cricenti, Simeon McMillan, Adam Pincus and Bradley M. Tirpak. The parties to this Agreement are each referred to as a “Party.”
JOINT FILING AGREEMENTJoint Filing Agreement • January 7th, 2020 • Camac Fund, LP • Operators of nonresidential buildings
This JOINT FILING AGREEMENT is entered into as of December 31, 2019, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of Common Stock of AmBase Corp. a Delaware corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Re: Termination of Group Agreement, dated August 16, 2023Termination of Group Agreement • June 17th, 2024 • Camac Fund, LP • Pharmaceutical preparations
The undersigned constitute all the parties to that certain Group Agreement dated August 16, 2023 (the “Agreement”). Effective immediately, the undersigned hereby terminate the Agreement in its entirety.
JOINT FILING AGREEMENTJoint Filing Agreement • October 8th, 2019 • Camac Fund, LP • Radio broadcasting stations
This JOINT FILING AGREEMENT is entered into as of October 7, 2019, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of common stock, par value $0.001 per share of Liberated Syndication Inc., a Nevada corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • January 8th, 2019 • Camac Fund, LP • Radio broadcasting stations
This JOINT FILING AGREEMENT is entered into as of December 31, 2018, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of Common Stock of Liberated Syndication Inc. a Nevada corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINDER AGREEMENTJoinder Agreement • September 1st, 2022 • Camac Fund, LP • Pharmaceutical preparations
The undersigned agrees, effective as of August 19, 2022, to become a party to the Joint Filing and Advocacy Agreement, dated May 31, 2022 (as it may be amended or restated from time to time, the “Joint Filing Agreement”), between (a) Concord IP2 Ltd., Elderhill Corporation and David Delaney; (b) Leonite Capital, LLC and Avi Geller; and (c) Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP and Eric Shahinian.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • March 5th, 2020 • Camac Fund, LP • Gold and silver ores
The undersigned acknowledge and agree that the foregoing statement of Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement of Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • March 18th, 2020 • Camac Fund, LP • Services-detective, guard & armored car services
The undersigned acknowledge and agree that the foregoing statement of Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement of Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
JOINDER AGREEMENTJoinder Agreement • May 25th, 2023 • Camac Fund, LP • Pharmaceutical preparations
This JOINDER AGREEMENT (the “Joinder”) is dated as of May 25, 2023, by and among Camac Fund, LP, Camac Partners, LLC, Camac Capital, LLC, Eric Shahinian, Michael G. Hacke and Chris McIntyre (collectively, the “Existing Members”), and McIntyre Partnerships, LP, McIntyre Capital GP, LLC, McIntyre Capital Management, LP and McIntyre Capital Management GP, LLC (collectively, the “New Members”).
JOINT FILING AGREEMENTJoint Filing Agreement • May 3rd, 2021 • Camac Fund, LP • Real estate investment trusts
This JOINT FILING AGREEMENT is entered into as of April 30, 2021 by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of common stock, par value $0.06 per share of Cedar Realty Trust, Inc., a Maryland corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • February 21st, 2023 • Camac Fund, LP • Pharmaceutical preparations
WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Forte Biosciences, Inc., a Delaware corporation (the “Company”); and
SETTLEMENT AND COOPERATION AGREEMENTSettlement and Cooperation Agreement • December 14th, 2022 • Camac Fund, LP • Pharmaceutical preparations • Delaware
This Settlement and Cooperation Agreement (the “Agreement”) is made and entered into as of December 9, 2022, by and among Pasithea Therapeutics Corp. (the “Company”), on the one hand, and Concord IP2 Ltd., Elderhill Corporation, Leonite Capital LLC, Leonite Fund I, LP, Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, David Delaney, Avi Geller, and Eric Shahinian (collectively, the “Investor Group Parties”), on the other hand (each of the Company and the Investor Group Parties, a “Party” and collectively, the “Parties”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 10th, 2023 • Camac Fund, LP • Pharmaceutical preparations • New York
This Stock Purchase Agreement (this “Agreement”), dated as of December 21st, 2022, is entered into among Concord IP2 Ltd., Elderhill Corporation, Leonite Capital LLC, Leonite Fund I, LP, Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP, David Delaney, Avi Geller, and Eric Shahinian (each a “Seller” and collectively the “Sellers”), and Pasithea Therapeutics Corp. (the “Buyer” or the “Company”). Capitalized terms used in this Agreement have the meanings given to such terms herein.
JOINT FILING AGREEMENTJoint Filing Agreement • November 9th, 2020 • Camac Fund, LP • Real estate investment trusts
This JOINT FILING AGREEMENT is entered into as of November 6, 2020, by and among the signatories hereto. The undersigned hereby agree that the statement on Schedule 13D with respect to the shares of common stock of Cedar Realty Trust Inc. a Maryland corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
ContractCooperation Agreement • January 19th, 2022 • Camac Fund, LP • Real estate investment trusts
GROUP AGREEMENTGroup Agreement • August 23rd, 2023 • Camac Fund, LP • Pharmaceutical preparations
WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Forte Biosciences, Inc., a Delaware corporation (the “Company”);
JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • March 1st, 2021 • Camac Fund, LP • Real estate investment trusts • Delaware
This joint filing and solicitation agreement (this “Agreement”), dated February 26, 2021, is between (a) Camac Fund, LP, Camac Partners, LLC, Camac Capital, LLC and Eric Shahinian (collectively, the “Camac Entities”); and (b) Larry E. Jennings, Jr., Daniel Katz, Eric Ray, Richard H. Ross, Sharon (Hochfelder) Stern, and Archer G. Stevenson. The parties to this Agreement are each referred to as a “Party.”
SHAREHOLDER AGREEMENTShareholder Agreement • May 7th, 2024 • Camac Fund, LP • Gold and silver ores
The undersigned, being the beneficial owner of, or having control or direction over, the number of Class A common shares in the capital of the Corporation indicated herein (each, a “Common Share”) as of the date hereof, hereby agrees as follows:
JOINT FILING AND ADVOCACY AGREEMENTJoint Filing and Advocacy Agreement • June 1st, 2022 • Camac Fund, LP • Pharmaceutical preparations • Delaware
This joint filing and advocacy agreement (this “Agreement”), dated as of May 31, 2022 (the “Effective Date”), is between (a) Concord IP2 Ltd., Elderhill Corporation and David Delaney (collectively the “Concord Persons”); (b) Leonite Capital, LLC and Avi Geller (collectively, the “Leonite Persons”); and (c) Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP and Eric Shahinian (collectively, the “Camac Persons”). The parties to this Agreement are each referred to as a “Party.”
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • August 7th, 2020 • Camac Fund, LP • Services-detective, guard & armored car services
The undersigned acknowledge and agree that the foregoing statement of Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement of Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
